PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

CFTR Modulator

CFTR modulator access, rare-disease pricing, payer criteria, evidence, and lifecycle strategy.

1 article·Lives underPricing & Access Specialty·Last updated 2026-05-27

Pricing & Access· May 27, 2026 · 12 min read

Trikafta and Alyftrek access guide: CFTR modulator genotype documentation, April 2026 label expansion, specialty pharmacy routing, and payer PA criteria

By Ran Chen#CFTR Modulator #Prior Authorization #Payer Policy